Polygenic scores and antidepressant treatment outcomes in major depression: a critical integrative review

Major depressive disorder (MDD) shows a large heterogeneity in antidepressant treatment outcome, a variability explained in part by common-variant liability captured by polygenic scores (PGSs). We performed a review of PubMed- and Google Scholar-indexed studies that related any PGS to treatment response, remission or resistance in adult MDD. Thirty-nine investigations met inclusion criteria. MDD-PGS emerged as the most consistently replicated predictor, each standard deviation increase raising…

via https://pubmed.ncbi.nlm.nih.gov/41127576/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1HYeX0emtvYgH07Wkz0a8n9otrdMd-JIklc_uo0I5vh1u9WMEy&fc=None&ff=20251025010805&v=2.18.0.post22+67771e2